Surgery, Gastroenterology and Oncology
Vol. 26, No. 2, Jun 2021
A Closer Look: Assessment of Acute Pancreatitis Prognosis Using Neutrophil-Lymphocyte Ratio
Telma Fonseca, João Miranda, Vitor Devezas, Marisa Aral, Rui Mendes Costa, J. Costa Maia
ORIGINAL PAPER, Jun 2021
Article DOI: 10.21614/sgo-26-2-296
Background/Objectives: Acute pancreatitis (AP) is a common cause of hospitalization and severe cases are usually associated with a poor prognosis. Neutrophil to lymphocyte ratio(NLR) has been pointed as an indicator of systemic inflammation in several disorders.
The aim of this study was to assess whether NLR at admission is able to predict severity of AP and some associated outcomes, while trying to establish the best cut-off value for outcomes. Materials and

Methods: Single-center, retrospective study, reviewing clinical data from AP patients admitted between January 2014 and December 2015. Four hundred and forty five patients were eligible for the study and NLR was calculated based on admission laboratory data. Patients were stratified according to severity, based on the Atlanta Classification, and comparative analysis was carried between groups.

Results: A total of 391 patients presented with mild AP and 54 with moderate or severe AP. NLR for the severe group was significantly higher than for the mild group (13.9 +-13.6 versus 10.1+-9.4, respectively).
There were also statistical differences in NLRs between all groups of analyzed outcomes except for in-hospital mortality. The best predictive NLR value for the stratification of AP severity was 9.2.

Conclusions: This study shows a significant correlation between NLR at admission and the severity of AP. Higher NLR values also predicted the development of organ failure, ICU admission and longer hospitalizations.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2727


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.